Ataxic Symptoms in Huntington's Disease Transgenic Mouse Model Are Alleviated by Chlorzoxazone

被引:14
|
作者
Egorova, Polina A. [1 ]
Gavrilova, Aleksandra V. [1 ]
Bezprozvanny, Ilya B. [1 ,2 ]
机构
[1] Peter Great St Petersburg Polytech Univ, Lab Mol Neurodegenerat, St Petersburg, Russia
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX USA
基金
俄罗斯科学基金会;
关键词
ataxia; cerebellum; Huntington's disease; transgenic mice; chlorzoxazone; BETA-III SPECTRIN; PURKINJE-CELLS; POTASSIUM CHANNELS; CEREBELLAR-ATAXIA; TRINUCLEOTIDE REPEAT; DOUBLE-BLIND; DYSFUNCTION; MOTOR; GENE; MODULATOR;
D O I
10.3389/fnins.2020.00279
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is a hereditary neurodegenerative disease caused by a polyglutamine expansion in the huntingtin protein, Striatum atrophy in HD leads to a progressive disturbance of psychiatric, motor, and cognitive function. Recent studies of HD patients revealed that the degeneration of cerebellum is also observed independently from the striatal atrophy during early HD stage and may contribute to the motor impairment and ataxia observed in HD. Cerebellar Purkinje cells (PCs) are responsible for the proper cerebellar pathways functioning and motor control. Recent studies on mouse models of HD have shown that the abnormality of the biochemical functions of PCs are observed in HD, suggesting the contribution of PC dysfunction and death to the impaired movement coordination observed in HD. To investigate ataxic symptoms in HD we performed a series of experiments with the yeast artificial chromosome transgenic mouse model of HD (YAC128). Using extracellular single-unit recording method we found that the portion of the cerebellar PCs with bursting and irregular patterns of spontaneous activity drastically rises in aged YAC128 HD mice when compared with wild type littermates. Previous studies demonstrated that SK channels are responsible for the cerebellar PC pacemaker activity and that positive modulation of SK channel activity exerted beneficial effects in different ataxic mouse models. Here we studied effects of the SK channels modulator chlorzoxazone (CHZ) on the motor behavior of YAC128 HD mice and also on the electrophysiological activity and neuroanatomy of the cerebellar PCs from these mice. We determined that the long-term intraperitoneal injections of CHZ alleviated the progressive impairment in the firing pattern of YAC128 PCs. We also demonstrated that treatment with CHZ rescued age-dependent motor incoordination and improved the cerebellar morphology in YAC128 mice. We propose that abnormal changes in the PC firing patterns might be a one of the possible causes of ataxic symptoms in HD and in other polyglutamine disorders and that the pharmacological activation of SK channels may serve as a potential way to improve the activity of cerebellar PCs and relieve the ataxic phenotype in HD patients.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model
    Chou, SY
    Lee, YC
    Chen, HM
    Chiang, MC
    Lai, HL
    Chang, HH
    Wu, YC
    Sun, CN
    Chien, CL
    Lin, YS
    Wang, SC
    Tung, YY
    Chang, C
    Chern, YJ
    JOURNAL OF NEUROCHEMISTRY, 2005, 93 (02) : 310 - 320
  • [2] Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
    Chen, Xi
    Wu, Jun
    Lvovskaya, Svetlana
    Herndon, Emily
    Supnet, Charlene
    Bezprozvanny, Ilya
    MOLECULAR NEURODEGENERATION, 2011, 6
  • [3] Metformin therapy in a transgenic mouse model of Huntington's disease
    Ma, Thong C.
    Buescher, Jessica L.
    Oatis, Benjamin
    Funk, Jason A.
    Nash, Andrew J.
    Carrier, Raeann L.
    Hoyt, Kari R.
    NEUROSCIENCE LETTERS, 2007, 411 (02) : 98 - 103
  • [4] Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
    Turmaine, M
    Raza, A
    Mahal, A
    Mangiarini, L
    Bates, GP
    Davies, SW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (14) : 8093 - 8097
  • [5] Striatal transplantation in a transgenic mouse model of Huntington's disease
    Dunnett, SB
    Carter, RJ
    Watts, C
    Torres, EM
    Mahal, A
    Mangiarini, L
    Bates, G
    Morton, AJ
    EXPERIMENTAL NEUROLOGY, 1998, 154 (01) : 31 - 40
  • [6] Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
    Xi Chen
    Jun Wu
    Svetlana Lvovskaya
    Emily Herndon
    Charlene Supnet
    Ilya Bezprozvanny
    Molecular Neurodegeneration, 6
  • [7] Valproate increases the survival in a transgenic mouse model of Huntington's disease
    Klivenyi, P.
    Zadori, D.
    Geisz, A.
    Vamos, E.
    Vecsei, L.
    MOVEMENT DISORDERS, 2010, 25 (07) : S273 - S273
  • [8] Therapeutic Effect of Berberine on Huntington's Disease Transgenic Mouse Model
    Jiang, Wenxiao
    Wei, Wenjie
    Gaertig, Marta A.
    Li, Shihua
    Li, Xiao-Jiang
    PLOS ONE, 2015, 10 (07):
  • [9] The role of carnosine administration in a transgenic mouse model of Huntington's disease
    Plangar, I.
    Zadori, D.
    Klivenyi, P.
    Vecsei, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 384 - 384
  • [10] Novel ethological endophenotypes in a transgenic mouse model of Huntington's disease
    Mo, Christina
    Renoir, Thibault
    Hannan, Anthony J.
    BEHAVIOURAL BRAIN RESEARCH, 2015, 276 : 17 - 27